Flow Diverters Market
According to Intent Market Research, the Flow Diverters Market is expected to grow from USD 0.9 Billion in 2024-e at a CAGR of 13.3% to touch USD 2.3 Billion by 2030. The Anticoagulant Reversal Drugs Market is dominated by key players such as Medtronic PLC, Stryker Corporation, Terumo Corporation, Johnson & Johnson (DePuy Synthes), Abbott Laboratories, Cerenovus (Johnson & Johnson)